5-minute meals linked an 81% higher risk of fatty liver disease, plus other benefits of slowing down
Slowmaxxing isn’t just a mood board of candles and quiet mornings. New research now ties fast eating to fatty liver risk.
An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...
While developer Fenris previously hesitated to use the term "extraction shooter," that's very much the core of EVE Vanguard's ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Introduction: Optimal ventilation during pediatric laparoscopic surgery is a debated issue, as pneumoperitoneum impairs respiratory mechanics and may increase ventilator-induced lung injury. Aim: We ...
The final set of your workout is about to get a lot more interesting.
CRDF READ THE FULL CRDF RESEARCH REPORT Updated Results from CRDF-004 Cardiff Oncology, Inc. (NASDAQ: CRDF) presented interim data from its CRDF-004 trial at the 2026 American Society of Clinical ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
Levacetylleucine (Aqneursa) improved functioning in a phase III crossover trial of adults and children with ataxia-telangiectasia. Two patients had three treatment-emergent adverse events; none were ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Morning Overview on MSN
A new pancreatic-cancer drug nearly doubled survival and cut the risk of death by 60%
Patients with previously treated metastatic pancreatic cancer lived nearly twice as long when given daraxonrasib compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results